Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ardelyx Inc (NQ: ARDX )

1.740 USD +0.030 (+1.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 83,731,707
Open 1.760
Bid (Size) 1.710 (205)
Ask (Size) 1.720 (7)
Prev. Close 1.710
Today's Range 1.670 - 1.920
52wk Range 1.510 - 9.230
Shares Outstanding 98,709,188
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Ardelyx, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
Investors with losses are encouraged to contact the firm before September 28, 2021; click here to submit trade information 
From GlobeNewswire News Releases
ARDELYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ardelyx, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX)... 
From Business Wire News Releases

Performance

YTD
-73.11%
-73.11%
1 Month
-78.11%
-78.11%
3 Month
-74.22%
-74.22%
6 Month
-75.00%
-75.00%
1 Year
-69.20%
-69.20%

More News

Read More
ARDX ALERT: Investors with Substantial Losses Have Opportunity to Lead the Ardelyx Inc. Class Action Lawsuit
From Business Wire News Releases
INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Ardelyx Inc. (NASDAQ: ARDX)
From Business Wire News Releases
Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX
From GlobeNewswire News Releases
REMINDER: Scott+Scott Attorneys at Law LLP Continues its Investigation into Ardelyx Inc. (ARDX)
From Business Wire News Releases
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tags BZI/TFM Markets SAVA
From Benzinga
Thinking about buying stock in Ardelyx, XpresSpa, Tellurian, Assertio, or Golden Star Resources?
From PR Newswire
Ardelyx's Tenapanor Application For Chronic Kidney Disease Receives FDA Response Letter
Tags Trading Ideas General Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.